The JAK-STAT Transcriptional Regulator, STAT-5, Activates the ATM DNA Damage Pathway to Induce HPV 31 Genome Amplification upon Epithelial Differentiation

PLoS Pathogens

Volumn 9, Issue 4, 2013, Pages

  Hong, Shiyuan ^a   Laimins, Laimonis A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; JANUS KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SHORT HAIRPIN RNA; STAT5 PROTEIN;

ARTICLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; DNA DAMAGE; EPITHELIUM CELL; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 31; IMMUNOSURVEILLANCE; INFLAMMATION; KERATINOCYTE; NORTHERN BLOTTING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SOUTHERN BLOTTING; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; WESTERN BLOTTING;

ALPHAPAPILLOMAVIRUS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; DNA DAMAGE; DNA REPAIR; EPITHELIAL CELLS; HUMANS; KERATINOCYTES; PAPILLOMAVIRUS E7 PROTEINS; PHOSPHORYLATION; PIMOZIDE; PPAR GAMMA; PROTEIN ISOFORMS; RNA INTERFERENCE; STAT5 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEINS; VIRUS REPLICATION;

HUMAN PAPILLOMAVIRUS;

EID: 84876866677     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003295     Document Type: Article

References (45)

1. zur Hausen H, (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350.
2. Moody CA, Laimins LA, (2010) Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10: 550-560.
3. Munger K, Howley PM, (2002) Human papillomavirus immortalization and transformation functions. Virus Res 89: 213-228.
4. Huibregtse JM, Scheffner M, Howley PM, (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10: 4129-4135.
5. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM, (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
6. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM, (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505.
7. Dyson N, Howley PM, Munger K, Harlow E, (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-937.
8. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, et al. (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8: 4099-4105.
9. Hong S, Mehta KP, Laimins LA, (2011) Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance. J Virol 85: 9486-9494.
10. Hughes FJ, Romanos MA, (1993) E1 protein of human papillomavirus is a DNA helicase/ATPase. Nucleic Acids Res 21: 5817-5823.
11. Conger KL, Liu JS, Kuo SR, Chow LT, Wang TS, (1999) Human papillomavirus DNA replication. Interactions between the viral E1 protein and two subunits of human dna polymerase alpha/primase. J Biol Chem 274: 2696-2705.
12. Oliveira JG, Colf LA, McBride AA, (2006) Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc Natl Acad Sci U S A 103: 1047-1052.
13. Poddar A, Reed SC, McPhillips MG, Spindler JE, McBride AA, (2009) The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes. J Virol 83: 640-650.
14. Hebner CM, Laimins LA, (2006) Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol 16: 83-97.
15. Moody CA, Laimins LA, (2009) Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog 5: e1000605.
16. Lee JH, Paull TT, (2004) Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 304: 93-96.
17. Roy R, Chun J, Powell SN, (2012) BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer 12: 68-78.
18. Aaronson DS, Horvath CM, (2002) A road map for those who don't know JAK-STAT. Science 296: 1653-1655.
19. Reich NC, Liu L, (2006) Tracking STAT nuclear traffic. Nat Rev Immunol 6: 602-612.
20. van Boxel-Dezaire AH, Rani MR, Stark GR, (2006) Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25: 361-372.
21. Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, et al. (2004) Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol Cell Biol 24: 8037-8047.
22. Yao Z, Cui Y, Watford WT, Bream JH, Yamaoka K, et al. (2006) Stat5a/b are essential for normal lymphoid development and differentiation. Proc Natl Acad Sci U S A 103: 1000-1005.
23. Nelson EA, Walker SR, Weisberg E, Bar-Natan M, Barrett R, et al. (2011) The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors. Blood 117: 3421-3429.
24. Krause K, Prawitt S, Eszlinger M, Ihling C, Sinz A, et al. (2011) Dissecting molecular events in thyroid neoplasia provides evidence for distinct evolution of follicular thyroid adenoma and carcinoma. Am J Pathol 179: 3066-3074.
25. Wakao H, Wakao R, Oda A, Fujita H, (2011) Constitutively active Stat5A and Stat5B promote adipogenesis. Environ Health Prev Med 16: 247-252.
26. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946.
27. Reddy PN, Sargin B, Choudhary C, Stein S, Grez M, et al. (2012) SOCS1 cooperates with FLT3-ITD in the development of myeloproliferative disease by promoting the escape from external cytokine control. Blood 120: 1691-1702.
28. Sobti RC, Singh N, Hussain S, Suri V, Bharadwaj M, et al. (2010) Deregulation of STAT-5 isoforms in the development of HPV-mediated cervical carcinogenesis. J Recept Signal Transduct Res 30: 178-188.
29. Heath C, Cross NC, (2004) Critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1. J Biol Chem 279: 6666-6673.
30. Sun Y, Jiang X, Chen S, Fernandes N, Price BD, (2005) A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc Natl Acad Sci U S A 102: 13182-13187.
31. Kim S, Lee JJ, Heo DS, (2011) PPARgamma ligands induce growth inhibition and apoptosis through p63 and p73 in human ovarian cancer cells. Biochem Biophys Res Commun 406: 389-395.
32. Olivo-Marston SE, Zhu Y, Lee RY, Cabanes A, Khan G, et al. (2008) Gene signaling pathways mediating the opposite effects of prepubertal low-fat and high-fat n-3 polyunsaturated fatty acid diets on mammary cancer risk. Cancer Prev Res (Phila) 1: 532-545.
33. Mighty KK, Laimins LA, (2011) p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation. J Virol 85: 8863-8869.
34. Menges CW, Baglia LA, Lapoint R, McCance DJ, (2006) Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res 66: 5555-5559.
35. Chen CC, Stairs DB, Boxer RB, Belka GK, Horseman ND, et al. (2012) Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways. Genes Dev 26: 2154-2168.
36. Kadaja M, Isok-Paas H, Laos T, Ustav E, Ustav M, (2009) Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog 5: e1000397.
37. Fradet-Turcotte A, Bergeron-Labrecque F, Moody CA, Lehoux M, Laimins LA, et al. (2011) Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J Virol 85: 8996-9012.
38. Sakakibara N, Mitra R, McBride AA, (2011) The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J Virol 85: 8981-8995.
39. Yoo J, Lee HN, Choi I, Choi D, Chung HK, et al. (2012) Opposing regulation of PROX1 by interleukin-3 receptor and NOTCH directs differential host cell fate reprogramming by Kaposi sarcoma herpes virus. PLoS Pathog 8: e1002770.
40. Migone TS, Lin JX, Cereseto A, Mulloy JC, O'Shea JJ, et al. (1995) Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269: 79-81.
41. Juffroy O, Bugault F, Lambotte O, Landires I, Viard JP, et al. (2010) Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway. J Virol 84: 96-108.
42. Mallette FA, Gaumont-Leclerc MF, Ferbeyre G, (2007) The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev 21: 43-48.
43. Fehrmann F, Laimins LA, (2005) Human papillomavirus type 31 life cycle: methods for study using tissue culture models. Methods Mol Biol 292: 317-330.
44. Hong S, Brass A, Seman M, Haag F, Koch-Nolte F, et al. (2007) Lipopolysaccharide, IFN-gamma, and IFN-beta induce expression of the thiol-sensitive ART2.1 Ecto-ADP-ribosyltransferase in murine macrophages. J Immunol 179: 6215-6227.
45. Melar-New M, Laimins LA, (2010) Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol 84: 5212-5221.